Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04780087
Other study ID # 170066
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date June 25, 2023

Study information

Verified date April 2024
Source Ostfold University College
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Despite the increase in numbers of women who engage in heavy, free-weight resistance exercise training (e.g. powerlifting, weightlifting, cross fit), the knowledge on how such exercise may affect fertility, pregnancy and birth outcomes is poor. Based on observational and associational studies of pregnant women in labour, recommendations are not to lift more than 11 kg in external load after mid-term, or to lift more than a total of 100 kg during a day. Ignoring such recommendations is associated to increased risk of miscarriage and preeclampsia, and of low birthweight and premature birth, respectively. As such, fit women who continue to exercise during pregnancy, are met with scepticism and warnings, resulting in shame and insecurity. Such attitudes may also result in physical inactivity during pregnancy, being on the contrary of what is recommended for a healthy pregnancy and delivery. Elite athletes may additionally be deprived from an early return to sport if not being able to keep exercise intensity close to pre-pregnancy period. With poor knowledge on how fit, strong women respond to high external loads during pregnancy exercise, recommendations are to follow the general guidelines. The aim of this observational study, is to explore how regular resistance exercise training may affect fertility, and how high external loads in resistance exercise training during pregnancy in resistance trained women affect; a)their pregnancy and birth outcome, and b)health of the women and their children up to 12 months post-delivery.


Description:

Pregnant women who are experienced in heavy, free-weight resistance exercise training, and who choose to continue their exercise regimes during pregnancy, are recruited in social media to regularly respond to an online questionnaire on personal health, foetus development, and the newborn child health. A reference group of pregnant women being regularly physical active (still not lifting free weights of high loads) are concurrently recruited. All will respond to questionnaire at mid-term, and week 23, 30 and 40 of pregnancy. During maternity leave the women will be asked to respond to questionnaires at 1 month, 3 months, 6 months and 12 months post-delivery.


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date June 25, 2023
Est. primary completion date June 25, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Being pregnant - Group of interest: Being experienced with heavy, free-weight resistance exercise training, and aiming to continue exercise at comparable level during pregnancy - Reference group: being regularly physical active before pregnancy (i.e. at least 2 work- outs per week), but not experienced in heavy, free-weight resistance exercise training Exclusion Criteria: - Any known metabolic condition or contraindication on doing physical activity during pregnancy (i.e. miscarriages, bleedings).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Norway Therese Fostervold Mathisen Fredrikstad

Sponsors (1)

Lead Sponsor Collaborator
Ostfold University College

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other Use of supplements Number of participants reporting use of dietary supplements, and what kind of supplements At pregnancy week 23, 30 and 40, and at 1 month-, 3months-, 6 months- and 12 months postdelivery,
Other Use of caffein (coffee, energydrinks, sodawater) Number of participants reporting use of caffein, and in what doses per day At pregnancy week 23, 30 and 40, and at 1 month-, 3months-, 6 months- and 12 months postdelivery,
Other Intake of alcohol Number of participants reporting intake of alcohol, and how regularly (choosing between no, daily, weekly, monthly) At pregnancy week 23, 30 and 40, and at 1 month-, 3months-, 6 months- and 12 months postdelivery,
Other Use of tobacco/cigarettes or snus Number of participants reporting any use At pregnancy week 23, 30 and 40, and at 1 month-, 3months-, 6 months- and 12 months postdelivery,
Other Use of any prescribed drugs Number of participants reporting any use, and what type of drug At pregnancy week 23, 30 and 40, and at 1 month-, 3months-, 6 months- and 12 months postdelivery,
Primary Delivery week The selfreported pregnancy week for delivery At delivery time
Primary Delivery method Participants report the method for delivery, choosing from natural delivery, delivery with assistance (e.g. birth forceps, vacuum delivery), caesarean section. At delivery time
Primary Pregnancy complications at week 23 Number of participants who report any complications during pregnancy, choosing from a list of alternatives (yes/no) (preeclampsia, nausea, fatigue, low back pain, pelvic pain, constipation, mood swings, birth anxiety, gestational depression, anemia, hypertension, pregnancy diabetes, foetus growth retardation) During pregnancy up to week 23
Primary Pregnancy complications at week 30 Number of participants who report any complications during pregnancy, choosing from a list of alternatives (yes/no) (preeclampsia, nausea, fatigue, low back pain, pelvic pain, constipation, mood swings, birth anxiety, gestational depression, anemia, hypertension, pregnancy diabetes, foetus growth retardation) Pregnancy week 23 to 30
Primary Pregnancy complications at week 40 Number of participants who report any complications during pregnancy, choosing from a list of alternatives (yes/no) (preeclampsia, nausea, fatigue, low back pain, pelvic pain, constipation, mood swings, birth anxiety, gestational depression, anemia, hypertension, pregnancy diabetes, foetus growth retardation) Pregnancy week 30 to 40
Primary Childs weight at birth The weight of the child At delivery time
Primary Childs length at birth The length of the child At delivery time
Primary Apgar score 5 minutes The Apgar score 5 minutes post-delivery. This test checks a baby's heart rate, muscle tone, and other signs to see if extra medical care or emergency care is needed. The test is usually given twice: once at 1 minute after birth, and again at 5 minutes after birth. Scores below 4 indicates need for lifesaving measures, and higher scores indicates better health. At delivery time (5 minutes post-delivery)
Primary Miscarriage Number of miscarriages Previous and up to October 2023
Primary Urinary incontinence before pregnancy Number of participants reporting any challenges with urinary incontinence, and if it occurs; if it is only during increased abdominal pressure (coughing, laughing), or heavy lifting (choosing from a list of "always", only during increased abdominal pressure, only during lifting of heavy load) Any experience before pregnancy
Primary Urinary incontinence during pregnancy Number of participants reporting any urinary incontinence, and if it occurs; if it is only during increased abdominal pressure (coughing, laughing), or heavy lifting (choosing from a list of "always", only during increased abdominal pressure, only during lifting of heavy load) At pregnancy week 23, 30 and 40
Primary Urinary incontinence after delivery Number of participants reporting any urinary incontinence, and if it occurs; if it is only during increased abdominal pressure (coughing, laughing), or heavy lifting (choosing from a list of "always", only during increased abdominal pressure, only during lifting of heavy load) Post-delivery: 1 month-, 3months-, 6 months- and 12 months
Primary Anal insufficiency before pregnancy Number of participants reporting any challenges with fecal incontinence Any experience before pregnancy
Primary Anal insufficiency during pregnancy Number of participants reporting any challenges with fecal incontinence At pregnancy week 23, 30 and 40
Primary Anal insufficiency after delivery Number of participants reporting any fecal incontinence and if it has worsened after giving birth Post-delivery: 1 month-, 3months-, 6 months- and 12 months
Primary Injuries during pregnancy up to week 23 Number of participants reporting on any exercise related injuries occuring during pregnancy, choosing from a list of anatomical locations During pregnancy up to week 23
Primary Injuries during pregnancy, up to week 30 Number of participants reporting on any exercise related injuries occuring during pregnancy, choosing from a list of anatomical locations Pregnancy week 23 to 30
Primary Injuries during pregnancy, up to week 40 Number of participants reporting on any exercise related injuries occuring during pregnancy, choosing from a list of anatomical locations (yes/no) Pregnancy week 30 to 40
Primary Analgesic during delivery Number of participants reporting use of analgesic during delivery, and what type of analgesic (e.g. nitrous oxide, epidural) At delivery time
Secondary Body weight at week 23 Participants report on body weight changes during pregnancy Pregnancy week 23
Secondary Body weight at week 30 Participants report on body weight changes during pregnancy Pregnancy week 30
Secondary Body weight at week 40 Participants report on body weight changes during pregnancy Pregnancy week 40
Secondary Body weight post-delivery, 1month Participants report on body weight changes after pregnancy Postpartum, 1 month after delivery
Secondary Body weight post-delivery, 3 months Participants report on body weight changes after pregnancy Postpartum, 3 months after delivery
Secondary Body weight post-delivery, 6 months Participants report on body weight changes after pregnancy Postpartum, 6 months after delivery
Secondary Body weight post-delivery, 12 months Participants report on body weight changes after pregnancy Postpartum, 12 months after delivery
Secondary Changes in external loads used in exercise training Participants report on changes in external loads used in exercise during pregnancy (% of normal loading used pre-pregnancy) During pregnancy
Secondary Changes in external loads used in exercise training, up to week 23 Participants report on changes in external loads used in exercise during pregnancy (% of normal loading used pre-pregnancy) During pregnancy, week 23
Secondary Changes in external loads used in exercise training Participants report on changes in external loads used in exercise after pregnancy (% of normal loading used pre-pregnancy) Post-delivery: 1 month-, 3months-, 6 months- and 12 months
Secondary Changes in exercise volume during pregnancy, up to week 23 Participants report on changes in exercise volume (number of sessions per week) during pregnancy During pregnancy, week 23
Secondary Changes in exercise volume during pregnancy, up to week 30 Participants report on changes in exercise volume (number of sessions per week) during pregnancy During pregnancy, week 30
Secondary Changes in exercise volume during pregnancy, up to week 40 Participants report on changes in exercise volume (number of sessions per week) during pregnancy During pregnancy, week 40
Secondary Changes in exercise volume after pregnancy Participants report on changes in exercise volume (number of sessions per week) after pregnancy Post-delivery: 1 month-, 3months-, 6 months- and 12 months
Secondary Injuries from exercise during maternity leave Reporting on any exercise related injuries occuring during maternity leave (up to 12 months post-delivery), choosing from a list of anatomical locations Post-delivery: 1 month-, 3months-, 6 months- and 12 months
Secondary Fertility Reports on any fertility problems or use of fertility techniques in order to become pregnant Before pregnancy
Secondary Bloodpressure Bloodpressure measures, and numbers above/below clinical cut offs (having hypo-or hypertension) At pregnancy week 23, 30 and 40, and at 1 month-, 3months-, 6 months- and 12 months postdelivery,
Secondary Symphysis-fundus measure symphysis fundus measure during pregnancy; as a measure for growth of the fetus, evaluated according to national/international standards At pregnancy week 23, 30 and 40
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A